GlassScriptPhysician profile
Heidi F Olson
NPI 1306110481
$2,974.54
in general payments reported to CMS, 2019-2025
19 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.39 · 2022: $1,003 · 2023: $578 · 2024: $1,113 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $689.93 | 2022-2025 | Omnipod |
| Medtronic, INC. | $267.87 | 2023-2024 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $224.38 | 2022-2024 | |
| Novo Nordisk INC | $210.83 | 2021-2024 | |
| Abbvie INC. | $171.63 | 2023-2024 | |
| Horizon Therapeutics Plc | $167.42 | 2022-2023 | Tepezza |
| Beta Bionics, INC. | $142.35 | 2024 | Ilet Bionic Pancreas |
| Abbott Laboratories | $124.21 | 2023 | Freestyle Libre 3 |
| Averitas Pharma INC. | $121.36 | 2023 | Qutenza |
| Corcept Therapeutics | $111.14 | 2024 | Korlym |
| Allergan, INC. | $109.81 | 2022 | |
| Phathom Pharmaceuticals, INC. | $104.02 | 2025 | Voquezna |
| Amgen INC. | $95.81 | 2022 | |
| Dexcom, INC. | $86.41 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $81.36 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $81.30 | 2022-2024 | Mounjaro |
| Ultragenyx Pharmaceutical INC. | $80.19 | 2022 | |
| Tandem Diabetes Care, INC. | $72.76 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.